Skip to content

The clinical use condition and security of Salvianolate injection

The clinical use condition and security of Salvianolate injection

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCS-13003907
Enrollment
Unknown
Registered
2013-11-28
Start date
2014-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease with patients used for Salvianolate injection

Interventions

Drug use group:non-intervention

Sponsors

Huzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 100 Years

Inclusion criteria

Inclusion criteria: All applications for Salvianolate injection of patients are more as the object

Exclusion criteria

Exclusion criteria: Do not set out standards

Design outcomes

Primary

MeasureTime frame
ADR;

Secondary

MeasureTime frame
use condition;

Countries

China

Contacts

Public ContactYao Chong

Huzhou Central Hospital

hzszxyy@qq.com+86 0572-2023301-6050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026